Alpha 2.0
Login Register
» Articles » PMID: 20095911

Tolerability of Two Different Combinations of Antiretroviral Drugs Including Tenofovir Used in Occupational and Nonoccupational Postexposure Prophylaxis for HIV

Overview
Journal AIDS Patient Care STDS
Specialty Infectious Diseases
Date 2010 Jan 26
PMID 20095911
Citations 4
Authors
Christine Burty
Thierry Prazuck
Francois Truchetet
Bernard Christian
Christian Penalba
Dominique Salmon-Ceron
Yazdan Yazdanpanah
Thierry May
Christian Rabaud
Affiliations
Soon will be listed here.
Citing Articles

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP).

Inciarte A, Ugarte A, Martinez-Rebollar M, Torres B, Fernandez E, Berrocal L Open Forum Infect Dis. 2023; 10(8):ofad374.

PMID: 37539061 PMC: 10394723. DOI: 10.1093/ofid/ofad374.

Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens.

Mayer K, Jones D, Oldenburg C, Jain S, Gelman M, Zaslow S J Acquir Immune Defic Syndr. 2017; 75(5):535-539.

PMID: 28696345 PMC: 5606152. DOI: 10.1097/QAI.0000000000001440.

Longitudinal trends in HIV nonoccupational postexposure prophylaxis use at a Boston community health center between 1997 and 2013.

Jain S, Oldenburg C, Mimiaga M, Mayer K J Acquir Immune Defic Syndr. 2014; 68(1):97-101.

PMID: 25321180 PMC: 4460007. DOI: 10.1097/QAI.0000000000000403.

Practical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial review.

Jain S, Mayer K AIDS. 2014; 28(11):1545-54.

PMID: 24785956 PMC: 4566923. DOI: 10.1097/QAD.0000000000000301.